Highlights of the week:
Al-Khatib to become President of HRS in 2026
We are pleased to share that Sana Al-Khatib, MD, MHS will become the President of the Heart Rhythm Society (HRS) in 2026 after serving terms as Second Vice-President (which she begins in May), and then as the Society’s First Vice-President and President-Elect over the coming years. Sana has been a dedicated volunteer with the Heart Rhythm Society since 2005 and is currently the Society’s Secretary/Treasurer.
HRS is the international leader in science, education and advocacy for cardiac arrhythmia professionals and patients. Its mission is to improve the care of patients by promoting research, education, and optimal health care policies and standards. The Society represents 7500 specialists in cardiac pacing and electrophysiology, consisting of physicians, scientists, and allied professionals. In the US, the HRS represents 3600 board-certified electrophysiologists.
“Serving the Heart Rhythm Society has been an amazing journey during which I have worked with inspiring clinicians, scientists, and staff, and have formed lifelong friendships and collaborations,” said Al-Khatib. “None of this would have been possible without the great support I have received from my Duke family. I am indebted to all of my mentors and supporters both within and outside of Duke.
“I am truly humbled by this recognition and greatly look forward to making a difference in this role for patients, our field, and the next generations of electrophysiologists.”
Congratulations, Sana!
Rymer to Receive SCAI’s 30 in Their 30s Award
Congratulations to Jenn Rymer, MD – she has been selected by the Society for Cardiovascular Angiography & Interventions (SCAI) as one of their 30 in Their 30s award winners! The SCAI 30 in Their 30s award recognizes early-career interventionalists who epitomize the qualities expected of future leaders in interventional cardiology.
Rymer and her co-winners will be recognized during SCAI’s 2023 Scientific Sessions scheduled for May 18-20, 2023 in Phoenix.
Congratulations, Jenn!
Duke Raleigh Earns GWTG Bronze Award, Target HF Honor Roll
Congratulations to our team at Duke Raleigh Hospital — they have achieved the 2022 Get With The 
Guidelines Heart Failure Bronze award level and the Target HF Honor Roll!
The American Heart Association’s Get With The Guidelines (GWTG) program is an in-hospital approach to improving patient outcomes across the cardiovascular and stroke care areas. Each GWTG program promotes consistent adherence to the latest research-driven guidelines and measurement, while also providing data for continual improvement in patient care.
“We know a lot of work has been done over the years with improving the care for our heart failure patients and it shows! Great work, and we look forward to continuing to learn being a part of the Get With The Guidelines program. Thanks for all you do.” — Julie Yamadi, director of Heart Services, Duke Raleigh
“Kudos to the entire DRAH team. This is such important and amazing work and service for the patients in Wake County. I look forward to continuing to partner and celebrate all of your tremendous contributions to Duke Heart and Duke Health! Thanks for all you do each and every day!” — Jill Engel, Service Line VP, Heart & Vascular, DUHS
Fantastic work all! Proud to be a part of an outstanding team that is delivering such excellent care to our heart failure patients in Wake County.” — James S. Mills, MD
Way to go, team!
7West Earns 2nd Beacon Gold Award
We are pleased to share with you that 7West has received its second Beacon Gold Award from the American Association of Critical-Care Nurses! The team won their initial award in 2020 and is one of only 175 units in the U.S. currently designated with a Gold award, which is the highest designation available.
Further, this makes the Duke 7W team the only Gold-level award-holding Cardiothoracic ICU in North Carolina, and just one of only 17 CTICU’s so designated in the U.S. A much smaller number have qualified for Gold-level more than once.
According to the AACN:
- Beacon awardees set the standard for excellence in patient care environments by collecting and using evidence-based information to improve patient outcomes, patient and staff satisfaction, and credibility with consumers
- A Beacon Award signifies a positive and supportive work environment with greater collaboration between colleagues and leaders, higher morale and lower turnover. The process can be driven by the nursing staff; nurturing empowerment and leadership
“Just as we did when we received a feedback report to identify unit strengths and opportunities for improvement in 2020, we will use the latest report to celebrate our strengths, but also work on opportunities to continue to improve the care we provide and improve the experience of our team members,” said Philip Parker, nurse manager of operations for the 7W CTICU. “A big thank you and great job to everyone on the team!”
The team has clearly worked hard to maintain their level of excellence and have continued to find even more ways to grow stronger.
“Congratulations to the entire 7West multidisciplinary team,” said Jill Engel, Service Line VP for Heart and Vascular. “The amazing work you do each and every day does not go unnoticed. Thanks to each and every one of you for all you do.”
We look forward to celebrating this accomplishment in the coming weeks – which may mean even more to all of us, given the strain of the last several years.
“You have maintained the highest of standards through a very difficult time,” added Jacob Schroder, MD, co-director, Cardiothoracic Surgical Intensive Care Unit. “We appreciate all you do to provide world class care for Duke patients.”
Outstanding news, team! Beacon Gold Award #2!!!
Betty Tong featured in Doctor’s Day piece
Betty Tong, MD, a surgical oncologist and thoracic surgeon in our division of cardiovascular and thoracic surgery, is featured in the March 27 issue of Duke Today. The article, Work Lessons from Duke Surgeons, was crafted to help celebrate National Doctor’s Day (March 30).
Tong is featured along with Drs. Laura Rosenberger, surgical oncologist; Chandler Long, vascular surgeon; and Dan Blazer, III, general surgeon and surgical oncologist.
Great job, Betty!
Kudos to Hausladen!
We received warm recognition for Jordan Hausladen, one of our terrific APPs in our Cardiac Intensive Care Unit. In a note from one of our patient advocates, we learned:
“I had the opportunity to speak with the daughter of one of our patients regarding her concerns while parent was a patient on 3100. Patient’s daughter shared that she was grateful that PA Jordon Hausladen took the time to explain what had happened and urgency to get patient transferred to 7E. Patient’s daughter additionally shared that she is happy with the communication from the care team on 7 East and wanted to mention that Lynette and Beverly are fantastic staff members along with everyone else.” — Shawn Parr, patient advocate, Patient Experience, Duke University Hospital
“Great job, Jordan! You’re fantastic at communicating with your patients and their families. The CICU team is lucky to have you!” — Jordan McKenzie-Solis
“Kudos and congrats Jordan! You are a tremendous provider and individual! We appreciate all you do for Duke Heart patients, families and staff. Duke Heart is a better place because of amazing team members like you!” — Jill Engel, Service Line VP, Heart & Vascular
Inaugural DOM Research Day: April 28
Consider joining the Department of Medicine for their inaugural Research Day on Friday, April 28, 2023, at the Trent Semans Center in the Great Hall from 8 a.m. until 1:30 p.m.
This event is for all departmental faculty, clinical and postdoctoral fellows, residents, medical students, and research staff. Lunch is included. For questions regarding Research Day contact Saini Pillai, MBA.
A copy of the agenda can be found here. Registration is required (deadline has passed, but maybe you can squeeze in). Please register here.
Duke Heart Represents at NCUS Spring Symposium
The 42nd annual Spring Symposium of the North Carolina Ultrasound Society was held March 10-12, 2023 at the Grove Park Inn in Asheville, NC. The meeting was well-attended and supported by Duke team members, including Richie Palma, program director of the Duke Cardiac Sonography Certificate Program and Jon Owensby, clinical lead sonographer of our Cardiac Diagnostic Unit, who were both installed as board members.
Lectures were given by Ashlee Davis, chief technologist of the Duke CDU, who presented Artificial Intelligence in Echocardiography; Palma Interesting Cases in Hemodynamics, and Owensby Mitral Regurgitation Quantification. Duke Heart Center 
and the DUHS Radiology Department co-sponsored a recruitment booth aimed at recruiting top sonographer talent for DUH/DRH/DRAH Adult Echo, DUHS General Ultrasound, Pediatric Echo, and PDC (DHIP) Adult Echo positions.
Well done, team! Congrats once again to Palma and Owensby for their Board membership!
Muir Named Vice Chair, Clinical Affairs for DOM, Effective April 1
Dr. Kathleen A. Cooney, Chair, Duke Department of Medicine, announced this week the appointment of Dr. Andrew Muir as Vice Chair of Clinical Affairs for the department.
She wrote:
“I am delighted to announce that after an internal search, Andrew Muir, MD, MHS, will serve as the next Vice Chair of Clinical Affairs for the Department of Medicine, beginning April 1. Dr. Muir will continue in his role as the Chief of the Division of Gastroenterology.
Dr. Muir is a Professor of Medicine in the Division of Gastroenterology and has served as Chief of the division since 2014. Prior to assuming the role of chief, he served as the Clinical Director of Hepatology for nine years, helping to facilitate the practice’s growth and expansion into Wake County and other areas of the Triangle. He is a nationally recognized hepatologist, known for both his research on health care disparities and novel hepatitis C therapies and his clinical care of patients with liver disease.
Muir earned his medical degree from Duke School of Medicine and went on to complete his residency in internal medicine and gastroenterology fellowship at Duke. During his fellowship, he spent time in the VA Health Services Research Program at the Durham VAMC, and completed the Masters in Health Sciences program in Clinical Research. He was recruited to join the Department after training and has been a member of the faculty since 2000.
As vice chair for clinical affairs, Dr. Muir will oversee the roadmap for clinical operations of the department. This oversight includes leading all aspects of our clinical practice and working closely with division clinical leads and our partners from the Health System and physician practice to ensure safe, effective care is provided to our patients. Dr. Muir has served as an At-Large Member of the Board of Managers of the PDC, which has provided him significant experiences in management and governance that will be useful in his new role.
I want to express my sincere appreciation to Dave D’Alessio and the members of the search committee for the time and effort they gave to this search. I also would like to thank Chet Patel for his outstanding service as Vice Chair; the department is stronger clinically because of his thoughtful guidance.
Please join me in congratulating Dr. Muir on his new role. Under his leadership, I believe the department will continue to make great strides towards advancing our clinical mission and importantly, improving the patient experience.
April is National Donate Life Month
Donate Life America takes the lead on National Donate Life Month (NDLM), an observance that aims to focus our national attention on the need for and importance of organ, eye and tissue donation. Living Donor Day is celebrated on April 5 and the Donate Life Blue & Green Spirit Week will be April 8-14.
Members of the Duke Heart cardiopulmonary team will host an awareness table outside of their clinic to share the Donate Life message by educating others about how their generosity can help save lives. Their table will be available April 10-14 from 10:30 a.m. to 2 p.m.
Please consider stopping by – our team will celebrate the lifesaving generosity of those who sign on as potential donors, as well as living donors, and will ultimately help others learn more about organ donation.
Support Marfan Patients & Duke Heart!
Please help Duke Heart in supporting patients with Marfan and other connective tissue disorders by supporting our efforts with the upcoming 2023 NC Walk for Victory.
The 2023 NC Walk for Victory is planned for Saturday, April 22 from Noon-3 p.m. at Laurel Hills Park, 3808 Edwards Mill Rd., Raleigh (27612). Duke Heart is serving as the presenting sponsor, with Dr. Chad Hughes serving as the Walk’s Medical Director.
This event is held to gather patients, family members and friends who are affected by genetic aortic and vascular conditions, including Marfan Syndrome, Loeys-Dietz, and Vascular Ehlers-Danlos syndromes. Attendees come from all over the southeast region of the U.S. to celebrate one another and to forge friendships with others going through similar experiences.
The Walk for Victory is a fun, family-friendly event that recognizes an incredible group of people and their caregivers. The Walk helps to create awareness in the community, and is one way the Marfan Foundation raises funding for much-needed research into these genetic conditions.
Please consider supporting any of the walkers/teams — maybe throw your support behind Duke Aorta and our team captain Melissa Burkett! Check out Duke Aorta’s team fundraising page for The Marfan Foundation: https://give.marfan.org/team/482581) or behind Team James (“giving hugs and raising awareness since 2018!”). Even small contributions will help!
To learn more about the event or the Marfan Foundation in general, please visit: https://duke.is/pkjnw. Thank you!
Quick Reminders & Updates
- 2022 DCRI Impact Report Now Available
- April is Donate Life Month and Celebrate Diversity Month
- DHIP: an APP Town Hall was held on 3/13. A recording is available on DHIP.org.
- New funding opportunity for fellows! See Mario Family Foundation Award announcement under Opportunities, below. Deadline to apply is May 1.
Upcoming Events & Opportunities
Cardiology Grand Rounds
April 25: Regulatory Guidance for Cardiovascular Outcomes Trials of Antihyperglycemic Agents: Connecting the Past with the Future with Darren K. McGuire, University of Texas Southwestern Medical Center & Parkland Health and Hospital System; Deputy Editor, Circulation. 5 p.m., DN 2002 and via Zoom.
ICYMI: Links to Recent CGRs
March 21: Emily S. Lau of Mass General and Harvard Medical School presentation, What Can Sex Differences Teach Us about HFpEF ? https://duke.is/9f78c (Please note, CGR begins at 00:12:05)
March 28: Gregory Roth, director of the Program in Cardiovascular Health Metrics and associate professor of medicine in cardiology at the University of Washington in Seattle, The Global Burden of Cardiovascular Diseases and Risks. https://duke.is/2j4hy.
Duke Root Causes Fundraising Gala
We are pleased to invite the Duke Heart team to the first annual Root Causes Fundraising Gala on Friday, April 14th from 7-9 p.m. at Trent Semans Center for Health Education.
Root Causes is an innovation hub for student-led interventions addressing social drivers of health. Our programs provide food to patients who are experiencing food insecurity, support patients experiencing homelessness in their housing journeys, and provide patients with metabolic diseases access to free exercise programs (among many other things we do!)
The event will feature dinner, drinks, a silent auction, and talks from special guests:
- Debra Clark Jones, Associate Vice President for Community Health for Duke Health
- Jeff Baker, Pediatrician and Medical Historian focusing on history, race and health disparities
- Susan Spratt, Endocrinologist and Clinical Researcher focusing on health disparities and ethical use of electronic medical records
The gala will bring together students, community members, and various stakeholders across Duke and the city of Durham to raise funds for our work, to highlight the ongoing work of our community partners in addressing social determinants of health, and to describe a collective vision for what uplifting our neighbors in Durham might look like.
We hope you consider supporting us by attending in person or making a donation online! Thank you in advance for your consideration, and feel free to forward this message to others who might be interested in the event.
Tickets are required and range from $30-55.
2023 Dean’s Research Series
The final date of the Dean’s Research Series will be Thursday, April 20. Full schedule and details can be found at medschool.duke.edu/research-series. The Zoom link for all faculty lectures is https://bit.ly/Duke-DDRS.
The Duke University School of Medicine’s Dean’s Distinguished Research Series showcases groundbreaking research from the basic, clinical, and translational sciences. All faculty, staff, trainees and students are welcome to attend.
2023 Loan Repayment Program to Promote Diversity and Inclusion in Medicine
The Duke Department of Medicine has announced the 2023 Loan Repayment Program to Promote Diversity and Inclusion in Medicine (LRPDIM). This award is part of a series of mentored career development opportunities offered by the Department of Medicine and is designed to fund members of groups underrepresented in medicine who, as a group, are disproportionately impacted by student loans. This financial burden impedes the retention, recruitment, and diversification of research faculty in our department.
We encourage investigators from diverse racial and ethnic backgrounds who are under-represented in Medicine to consider applying. The LRPDIM award repays up to $50,000, annually for up to two years, of a researcher’s qualified educational debt in return for a commitment to engage in research. Up to two applicants will be funded (July 1, 2023, through June 30, 2025). The award recipient must remain a full-time employee of the DOM to receive the full amount of the award. Award funds are not restricted and can be used at the awardee’s discretion. If the research commitment is not met, recipients must pay back the amount awarded.
The 2023 LRPDIM Award application deadline is May 12, 2023, at 5 p.m. Eligibility criteria, detailed information about the Award, and the application form are available on the DOM Loan Repayment Program to Promote Diversity and Inclusion website. For program-related questions, please contact Kimberly Dorman, Special Assistant to the Vice Chair for Faculty Development and Diversity in the Chair’s Office.
1st Open BAA for innovative high-impact research proposals
ARPA-H opened its first Agency-wide Open Broad Agency Announcement (Open BAA), seeking funding proposals for research aiming to improve health outcomes across patient populations, communities, diseases, and health conditions. The BAA calls for proposals to outline breakthrough research and technological advancements.
Proposals should investigate unconventional approaches, and challenge accepted assumptions to enable leaps forward in science, technology, systems, or related capabilities. ARPA-H also encourages concepts to advance the objectives of President Biden’s Cancer Moonshot, as well as more disease-agnostic approaches.
For questions, please contact baaquestions@arpa-h.gov
Funding Opportunity: The Mario Family Foundation Award
Training the next generation of biomedical researchers is an important core mission of the Department of Medicine. We admit the most promising, dedicated fellows into our programs, and provide experiences that will allow them to put their passion for medicine to work. These fellows will be tomorrow’s leaders in science and medicine. The Mario Family Foundation has generously supported this mission to support junior investigators in training to make the transition to become independent scientists and planning for their first extra-mural funding.
The Department of Medicine is accepting applications from fellows in specialty training for the Mario Family Foundation Award, which funds two patient-oriented research (clinical or translational) proposals for one year of funding. The total funding for all proposal expenses is $35,000.
Applications must be submitted electronically no later than Monday, May 1, 2023, 5p.m.
Applications will be peer reviewed by a panel of senior scientists from the Department of Medicine. Proposals will be judged on scientific-merit, rigor, and quality of project. Our intent is to complete reviews and start funding by July 1, 2023.
Additional details and application information can be found on the Mario Family Foundation Award webpage. For project-related questions, please contact Saini Pillai, MBA, Senior Program Coordinator, Chair’s Office.
Cardiac Safety Research Consortium Think Tank Meeting, June 7
The Cardiac Safety Research Consortium will hold a Think Tank meeting on June 7. The event, CSRC Think Tank: Update on Regulatory Status of Hypertension, Biomarkers and Arrhythmia Monitoring in Clinical Trials will be held at the FDA.
In Session 1, these leading industry professionals will speak on panels discussing:
- Regulations for ECG/QT
- The double-negative conundrum
- Alternative methods for assay sensitivity assessment in routine Phase 1 QT Studies
- Covid-19 and prolonged QT
In Session 2, we will discuss:
- Small increases in blood pressure and CV risk I
- Intermittent versus chronic use hypertension drugs
In Session 3, the meeting faculty will dive into:
- Biomarkers
In Session 4, the panelists will discuss hot topics in the field such as:
- Biologics/cardiomyopathy and vaccine development
- MACE
- Gene therapies
- Wearables
The event will include professionals from FDA Regulatory, Cardiac Safety Consultants, Ltd., Eli Lilly, Richmond Pharmacology, University of Connecticut, Stanford University, University of Pennsylvania, Cleveland Clinic, Clario, Mass General, DSI, Penn Medicine, and UCSF.
There is a registration fee for attendance, for academics it is $275. Registration and more information is available here: https://cardiac-safety.org/
The meeting will be held in person; a recording of the meeting and slide presentations will become available a month after the event occurs.
Have news to share?
If you have news to share with the Pulse readership, please contact Tracey Koepke, director of communications for Duke Heart at tracey.koepke@duke.edu. We would love to hear about your latest accomplishments, professional news, cool happenings, and any events or opportunities that may be of interest to our Duke Heart family. Please call with any questions: 919-681-2868. Feedback on Pulse is welcome and encouraged. Submissions by Noon, Wednesdays, to be considered for weekend inclusion.
Duke Heart in the News:
March 15 — Harry Severance
KevinMD.com
An unspoken truth about non-compete clauses in medicine
https://duke.is/pwqqj
March 16 — Zebulon Spector and the Joe family
MSN South Africa
Mom saves daughter’s life after she suffered a cardiac arrest
https://duke.is/geyrc
March 17 — Zebulon Spector and the Joe family
Black Enterprise
Cheer mom saves daughter after she goes into cardiac arrest at competition
https://duke.is/6yy3u
March 19 — Harry Severance
KevinMD.com
Can AI solve the physician shortage crisis?
https://duke.is/4f4gq
March 20 — Zebulon Spector and the Joe family
WAND NBC, Champagne-Springfield-Decatur, IL
Cheerleader goes into cardiac arrest during competition
https://duke.is/5mt9r
March 21 — Manesh Patel
Huffpost.com
These Sleep Habits Are Putting Your Heart Health At Risk
https://duke.is/nv4tx
March 22 – Robert Mentz
Medical News Today
Heart failure: Study finds similar survival rates between drugs furosemide and torsemide
https://duke.is/b3yy7
March 22 — Marat Fudim
tctMD
Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF
https://duke.is/4p7kw
March 23 — Adam DeVore
Medscape
Does New Heart Transplant Method Challenge Definition of Death?
https://duke.is/bbtu6
March 23 — Neha Pagidipati
MIMS/Pharmacy
Coordinated care improves use of CVD-preventive therapies in T2D
https://duke.is/cxm8f
March 24 — Keianna Joe, Andrea Joe, Duke Health
Mix 97.3/iheart radio
NC Mom Saves Teen Daughter After Heart Attack at Cheer Competition
https://duke.is/wk7p4
March 24 — G. Michael Felker and Stephanie Barnes
Medscape
Shared Decision-Making in Heart Failure
https://duke.is/j5hnk
March 24 — Adam DeVore
Medscape
A ‘Game Changer’ for Heart Transplant: Donation After Circulatory Death Explained
https://duke.is/yh4j2
March 27 — Andrew Landstrom
newsroom.heart.org
Genetic tests unexpectedly find genes linked to heart disease — now what?
https://duke.is/z2qhv
March 27 — Andrew Landstrom
SciTech Daily
Genes Linked to Heart Disease Unexpectedly Found in Genetics Tests – Now What?
https://duke.is/v6y7m
March 27 — Andrew Landstrom
News-medical.net
https://duke.is/mdhr8
March 27 — Andrew Landstrom
Healio/Cardiology
Navigating incidental genetic findings for CVD requires caution, established framework
https://duke.is/8t4v
March 28 — Neha Pagidipati and Vishal Rao
WebMD
Weight Loss Benefits Persist Even After Regaining Some Pounds
https://duke.is/cryeg
March 28 — Antonio Gutierrez
WGHP Fox 8 News
You may be prescribed walking to improve your health
https://duke.is/r9xm9
(*clip begins @ 09:23:38)
March 28 — Neha Pagidipati
The Telegraph (UK)
Don’t worry if you gain a few pounds after a diet, you’re still healthier
https://duke.is/57yne
March 28 — Monique Starks
WNCN – CBS17.com
https://duke.is/nxxpb
March 29 — Duke Health (Monique Starks)
WJZY – Fox 46 Carolinas – Queen City News Now
Drone delivery of AEDs may help quick heart attack response
https://duke.is/w8qtd
(*clip begins @ 05:59:07)
March 29 — Antonio Gutierrez
ABC4.com
Can You Really Walk Your Way to Better Health?
https://duke.is/6qm9p
March 29 — Stephen Greene
HCP Live
10 Years of SGLT2 Inhibitors: A Decade of Redefining Cardiometabolic Care
https://duke.is/yn75h
Division of Cardiology Publications Indexed in PubMed March 16-30, 2023
Abbas H, Olivere LA, Padgett ME, Schmidt CA, Gilmore BF, McCord TJ, Southerland KW, McClung JM, Kontos CD. Muscle progenitor cells are required for skeletal muscle regeneration and prevention of adipogenesis after limb ischemia. Front Cardiovasc Med 2023 Mar 2;10:1118738. PM: 36937923.
Chew DS, Piccini JP. Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation. Ann Intern Med 2023 Mar;176(3):eL220517. PM: 36940461.
Chouairi F, Pinsker B, Fudim M, Miller PE. Trends in outcomes and resource utilization for acute myocardial infarction admissions during the COVID-19 pandemic. Am Heart J 2023 Apr;258:114-118. PM: 36646197.
Delewi R, Vogel RF, Wilschut JM, Lemmert ME, Diletti R, van Vliet R, van der Waarden NWPL, Nuis RJ, Paradies V, Alexopoulos D, Zijlstra F, Montalescot G, Angiolillo DJ, Krucoff MW, Doevendans PA, Van Mieghem NM, Smits PC, Vlachojannis GJ. Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST- segment elevation myocardial infarction. Am Heart J 2023 Apr;258:17-26. PM: 36596332.
Denoble AE, Moyett JM, Goldstein SA, Ward CC, Truong T, Erkanli A, James AH, Grotegut CA. Prospective Observational Study of N-terminal Pro-Brain Natriuretic Peptide Levels in Obese and Nonobese Women during Pregnancy. Am J Perinatol 2023 Apr;40(5):467-474. PM: 35973801.
Eudy AM, Rogers JL, Corneli A, McKenna K, Maheswaranathan M, Pisetsky DS, Criscione- Schreiber LG, Doss J, Sadun RE, Sun K, Clowse MEB. Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms. Lupus Sci Med 2022 Aug;9(1):e000705. PM: 36927502.
Gaudino M, Di Franco A, Rong LQ, Piccini J, Mack M. Postoperative atrial fibrillation: from mechanisms to treatment. Eur Heart J 2023 Mar 21;44(12):1020-1039. PM: 36721960.
Govsyeyev N, Nehler M, Conte MS, Debus S, Chung J, Dorigo W, Gudz I, Krievins D, Mills J, Moll F, Norgren L, Piffaretti G, Powell R, Szalay D, Sillesen H, Wohlauer M, Szarek M, Bauersachs RM, Anand SS, Patel MR, Capell WH, Jaeger N, Hess CN, Muehlhofer E, Haskell LP, Berkowitz SD, Bonaca MP. Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits. J Vasc Surg 2023 Apr;77(4):1107-1118.e2. PM: 36470531.
Hamid A, Yimer WK, Oshunbade AA, Kamimura D, Clark D, Fox ER, Min YI, Muntner P, Shimbo D, Pandey A, Shah AM, Mentz RJ, Jones DW, Bertoni AG, Hall JE, Correa A, Butler J, Hall ME. Impact of Diabetes and Hypertension on Left Ventricular Structure and Function: The Jackson Heart. J Am Heart Assoc 2023 Mar 21;12(6):e026463. PM: 36880997.
Jenista ER, Wendell DC, Azevedo CF, Klem I, Judd RM, Kim RJ, Kim HW. Revisiting how we perform late gadolinium enhancement CMR: insights gleaned over 25 years of clinical practice. J Cardiovasc Magn Reson 2023 Mar 16;25(1):18. PM: 36922844.
Khedraki R, Abraham J, Jonsson O, Bhatt K, Omar HR, Bennett M, Bhimaraj A, Guha A, McCann P, Muse ED, Robinson M, Sauer AJ, Cheng A, Bagsic S, Fudim M, Heywood JT, Guglin M. Impact of exercise on pulmonary artery pressure in patients with heart failure using an ambulatory pulmonary artery pressure monitor. Front Cardiovasc Med 2023 Mar 2;10:1077365. PM: 36937902.
Loring Z, Giczewska A, Hofmann P, Chiswell K, Schlegel TT, Ugander M, Jackson KP, Piccini JP, Atwater BD. Electrocardiographic parameters associated with pacemaker induced cardiomyopathy. J Electrocardiol 2023 ;77:17-22. PM: 36549180.
Meng ML, Frere Z, Fuller M, Li YJ, Habib AS, Federspiel JJ, Wheeler SM, Gilner JB, Shah SH, Ohnuma T, Raghunathan K, Krishnamoorthy V. Maternal Cardiovascular Morbidity Events Following Preeclampsia: A Retrospective Cohort Study. Anesth Analg 2023 Apr 1;136(4):728-737. PM: 36729641.
Naggie S, Boulware DR, Lindsell CJ, Stewart TG, Slandzicki AJ, Lim SC, Cohen J, Kavtaradze D, Amon AP, Gabriel A, Gentile N, Felker GM, Jayaweera D, McCarthy MW, Sulkowski M, Rothman RL, Wilson S, DeLong A, Remaly A, Wilder R, Collins S, Dunsmore SE, Adam SJ, Thicklin F, Hanna GJ, Ginde AA, Castro M, McTigue K, Shenkman E, Hernandez AF. Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial. JAMA 2023 Mar 21;329(11):888-897. PM: 36807465.
Naggie S, Milstone A, Castro M, Collins SP, Lakshmi S, Anderson DJ, Cahuayme-Zuniga L, Turner KB, Cohen LW, Currier J, Fraulo E, Friedland A, Garg J, George A, Mulder H, Olson RE, O’Brien EC, Rothman RL, Shenkman E, Shostak J, Woods CW, Anstrom KJ, Hernandez AF. Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ). Int J Infect Dis 2023 Apr;129:40-48. PM: 36682681.
Rao VN, Diez J, Gustafsson F, Mentz RJ, Senni M, Jankowska EA, Bauersachs J. Practical Patient Care Considerations With Use of Vericiguat After Worsening Heart Failure Events. J Card Fail 2023 Mar;29(3):389-402. PM: 36529314.
Rikken SAOF, Selvarajah A, Hermanides RS, Coller BS, Gibson CM, Granger CB, Lapostolle F, Postma S, van de Wetering H, van Vliet RCW, Montalescot G, Ten Berg JM, van ‘t Hof AWJ. Prehospital treatment with zalunfiban (RUC-4) in patients with ST- elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial. Am Heart J 2023 Apr;258:119-128. PM: 36592878.
Scott M, Baykaner T, Bunch TJ, Piccini JP, Russo AM, Tzou WS, Zeitler EP, Steinberg BA. Contemporary trends in cardiac electrophysiology procedures in the United States, and impact of a global pandemic. Heart Rhythm O2 2023 Mar;4(3):193-199. PM: 36569386.
Yao RJR, Holmes DN, Andrade JG, Levin A, Piccini JP, Fordyce CB. Variability in Nonvitamin K Oral Anticoagulant Dose Eligibility and Adjustment According to Renal Formulae and Clinical Outcomes in Patients With Atrial Fibrillation With and Without Chronic Kidney Disease: Insights From ORBIT-AF II. J Am Heart Assoc 2023 Mar 21;12(6):e026605. PM: 36892077.
Baksh SS, Hu J, Pratt RE, Dzau VJ, Hodgkinson CP. Rig1 receptor plays a critical role in cardiac reprogramming via YY1 signaling. Am J Physiol Cell Physiol 2023 Apr 1;324(4):C843-C855. PM: 36847443.
Bethel MA, Sourij H, Stevens SR, Hannan K, Lokhnygina Y, Adler AI, Peterson ED, Holman RR, Lopes RD. Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease. Cardiovasc Diabetol 2023 Mar 28;22(1):72. PM: 36978066.
Carnicelli AP, Agarwal R, Tedford RJ, Ramaiah V, Felker GM, Katz JN. Critical Care Enrichment During Advanced Heart Failure Training. J Am Coll Cardiol 2023 Apr 4;81(13):1296-1299. PM: 36990549.
Chu MWA, Ruel M, Graeve A, Gerdisch MW, Damiano RJ, Smith RL, Keeling WB, Wait MA, Hagberg RC, Quinn RD, Sethi GK, Floridia R, Barreiro CJ, Pruitt AL, Accola KD, Dagenais F, Markowitz AH, Ye J, Sekela ME, Tsuda RY, Duncan DA, Swistel DG, Harville LE, DeRose JJ, Lehr EJ, Alexander JH, Puskas JD. Low-Dose vs Standard Warfarin After Mechanical Mitral Valve Replacement: A Randomized Trial. Ann Thorac Surg 2023 Apr;115(4):929-938. PM: 36610532.
Gerstein HC, Li Z, Ramasundarahettige C, Baek S, Branch KRH, Del Prato S, Lam CSP, Lopes RD, Pratley R, Rosenstock J, Sattar N. Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial. Circulation 2023 Mar 28;147(13):1004-1013. PM: 36802715.
Lakkireddy DR, Segar DS, Sood A, Wu M, Rao A, Sohail MR, Pokorney SD, Blomström-Lundqvist C, Piccini JP, Granger CB. Early Lead Extraction for Infected Implanted Cardiac Electronic Devices: JACC Review Topic of the Week. J Am Coll Cardiol 2023 Apr 4;81(13):1283-1295. PM: 36990548.
Li A, Liu S, Huang R, Ahn S, Lefkowitz RJ. Loss of biased signaling at a G protein-coupled receptor in overexpressed systems. PLoS One 2023 Mar 24;18(3):e0283477. PM: 36961836.
Lusk JB, Song A, Unnithan S, Al-Khalidi HR, Delic A, de Havenon A, Biousse V, Schrag M, Poli S, Piccini JP, Xian Y, O’Brien EC, Mac Grory B. Association Between Hospital-Documented Atrial Fibrillation and Central Retinal Artery Occlusion. Stroke 2023 Apr;54(4):983-991. PM: 36729390.
Neighbors CE, Sloane R, Pieper CF, Wixted D, Woods CW, Newby LK. Mitigation behavior prior to COVID-19 vaccination availability is associated with COVID-19 infection and time to vaccination. PLoS One 2023 Mar 24;18(3):e0283381. PM: 36961840.
Rashid AM, Khan MS, Fudim M, DeWald TA, DeVore A, Butler J. Management of Heart Failure With Reduced Ejection Fraction. Curr Probl Cardiol 2023 May;48(5):101596. PM: 36681212.
Richter MJ, Fortuni F, Alenezi F, D’Alto M, Badagliacca R, Brunner NW, van Dijk AP, Douschan P, Gall H, Ghio S, Giudice FL, Grünig E,
Haddad F, Howard L, Rajagopal S, Stens N, Stolfo D, Thijssen DHJ, Vizza CD, Zamanian RT, Zhong L, Seeger W, Ghofrani HA, Tello K. Imaging the right atrium in pulmonary hypertension: A systematic review and meta-analysis. J Heart Lung Transplant 2023 Apr;42(4):433-446. PM: 36610927.
Salah HM, Savarese G, Rosano GMC, Ambrosy AP, Mentz RJ, Fudim M. Intravenous iron infusion in patients with heart failure: a systematic review and study-level meta-analysis. ESC Heart Fail 2023 Apr;10(2):1473-1480. PM: 36734033.
Teng TK, Tay WT, Ouwerkerk W, Tromp J, Richards AM, Gamble G, Greene SJ, Yiu KH, Poppe K, Ling LH, Lund M, Sim D, Devlin G, Loh SY,
Troughton R, Ren QW, Jaufeerally F, Lee SGS, Tan RS, Soon DKN, Leong G, Ong HY, Yeo DPS, Lam CSP, Doughty RN. Titration of medications and outcomes in multi-ethnic heart failure cohorts (with reduced ejection fraction) from Singapore and New Zealand. ESC Heart Fail 2023 Apr;10(2):1280-1293. PM: 36722315.
Recent Comments